Scientists. Researchers. Barrier Breakers.
We Strive for the Awesome.

About InVivo Biosystems

InVivo Biosystems provides essential services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions around the globe accelerate their research and drug development efforts.

An expert in CRISPR genome editing, InVivo Biosystems creates custom genome edited C. elegans and zebrafish models to enable aging, developmental and disease studies. InVivo Biosystems also develops and manufactures genotyping and phenotyping products, including instruments, reagents and consumables to allow researchers to explore and discover new phenotypes.

In addition, InVivo Biosystems provides in-vivo analytical services to produce data and insights for companies that need to make go/no-go decisions quickly, and advance the discovery and early-stage development of new compounds.

Our Management Team

Messages Image(827828973)
Matt Beaudet
Chief Executive Officer
Janis Weeks, Ph.D.
Co-Founder & Chief Global Health Officer
Chris Hopkins, Ph.D.
Chief Scientific Officer
Wenlan Hu, MBA
VP of Marketing
Dr. Sarah Cheesman - zebrafish expert
Sarah Cheesman, Ph.D.
Director of Sales

Harold Holman
Harold Holman
Director of Operations

Dr. Tricia Brock
Trisha Brock, Ph.D.
Director of Research & Technical Delivery
Kat McCormick
Kat McCormick, Ph.D.
Director of Business Development

Our Board of Directors

Ann Bunnenberg
CEO, White Horse Consulting LLC
Evangeline Gonzalez
Sr. VP of Corporate Strategy, BD Biosciences
Dr. Shawn Lockery
Shawn Lockery
Co-Founder, CTO, InVivo Biosystems
Rick Miller
Co-Founder, Rogue Venture Partners

C. Palani Palaniappan
Chief Innovation Officer, Ortho Clinical Diagnostics

Ready to connect with us to learn more about working with our company or our technology?

Scroll to Top